717 related articles for article (PubMed ID: 14967065)
1. The use of vitamin K in patients on anticoagulant therapy: a practical guide.
Hanslik T; Prinseau J
Am J Cardiovasc Drugs; 2004; 4(1):43-55. PubMed ID: 14967065
[TBL] [Abstract][Full Text] [Related]
2. Four-factor prothrombin complex concentrate for life-threatening bleeds or emergent surgery: A retrospective evaluation.
Sin JH; Berger K; Lesch CA
J Crit Care; 2016 Dec; 36():166-172. PubMed ID: 27546767
[TBL] [Abstract][Full Text] [Related]
3. Vitamin K dosing to reverse warfarin based on INR, route of administration, and home warfarin dose in the acute/critical care setting.
Tsu LV; Dienes JE; Dager WE
Ann Pharmacother; 2012 Dec; 46(12):1617-26. PubMed ID: 23249867
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness and safety of a management protocol to correct over-anticoagulation with oral vitamin K: a retrospective study of 1,043 cases.
Denas G; Marzot F; Offelli P; Stendardo A; Cucchini U; Russo R; Nante G; Iliceto S; Pengo V
J Thromb Thrombolysis; 2009 Apr; 27(3):340-7. PubMed ID: 18338109
[TBL] [Abstract][Full Text] [Related]
5. Assessment of the efficacy of a novel tailored vitamin K dosing regimen in lowering the International Normalised Ratio in over-anticoagulated patients: a randomised clinical trial.
Kampouraki E; Avery PJ; Wynne H; Biss T; Hanley J; Talks K; Kamali F
Br J Haematol; 2017 Sep; 178(5):800-809. PubMed ID: 28771671
[TBL] [Abstract][Full Text] [Related]
6. Vitamin K for improved anticoagulation control in patients receiving warfarin.
Mahtani KR; Heneghan CJ; Nunan D; Roberts NW
Cochrane Database Syst Rev; 2014 May; (5):CD009917. PubMed ID: 24832594
[TBL] [Abstract][Full Text] [Related]
7. [Bleeding risk and perioperative management of patients anticoagulated with vitamin K antagnosists].
Angelo M; Stockner I; Wiedermann CJ
Wien Med Wochenschr; 2008; 158(21-22):615-20. PubMed ID: 19052707
[TBL] [Abstract][Full Text] [Related]
8. Low-dose oral vitamin K is safe and effective for outpatient management of patients with an INR>10.
Gunther KE; Conway G; Leibach L; Crowther MA
Thromb Res; 2004; 113(3-4):205-9. PubMed ID: 15140584
[TBL] [Abstract][Full Text] [Related]
9. Oral vitamin K versus placebo to correct excessive anticoagulation in patients receiving warfarin: a randomized trial.
Crowther MA; Ageno W; Garcia D; Wang L; Witt DM; Clark NP; Blostein MD; Kahn SR; Vesely SK; Schulman S; Kovacs MJ; Rodger MA; Wells P; Anderson D; Ginsberg J; Selby R; Siragusa S; Silingardi M; Dowd MB; Kearon C
Ann Intern Med; 2009 Mar; 150(5):293-300. PubMed ID: 19258557
[TBL] [Abstract][Full Text] [Related]
10. An update of consensus guidelines for warfarin reversal.
Tran HA; Chunilal SD; Harper PL; Tran H; Wood EM; Gallus AS;
Med J Aust; 2013 Mar; 198(4):198-9. PubMed ID: 23451962
[TBL] [Abstract][Full Text] [Related]
11. Appraisal of current vitamin K dosing algorithms for the reversal of over-anticoagulation with warfarin: the need for a more tailored dosing regimen.
Sconce EA; Kamali F
Eur J Haematol; 2006 Dec; 77(6):457-62. PubMed ID: 17042764
[TBL] [Abstract][Full Text] [Related]
12. Optimal dose of prothrombin complex concentrate for acute reversal of oral anticoagulation.
Yasaka M; Sakata T; Naritomi H; Minematsu K
Thromb Res; 2005; 115(6):455-9. PubMed ID: 15792675
[TBL] [Abstract][Full Text] [Related]
13. Management of coumarin-associated coagulopathy in the non-bleeding patient: a systematic review.
Dentali F; Ageno W
Haematologica; 2004 Jul; 89(7):857-62. PubMed ID: 15257939
[TBL] [Abstract][Full Text] [Related]
14. Prothrombin complex concentrates to reverse warfarin-induced coagulopathy in patients with intracranial bleeding.
Cabral KP; Fraser GL; Duprey J; Gibbons BA; Hayes T; Florman JE; Seder DB
Clin Neurol Neurosurg; 2013 Jun; 115(6):770-4. PubMed ID: 22835715
[TBL] [Abstract][Full Text] [Related]
15. Treatment of excessive anticoagulation with phytonadione (vitamin K): a meta-analysis.
Dezee KJ; Shimeall WT; Douglas KM; Shumway NM; O'malley PG
Arch Intern Med; 2006 Feb; 166(4):391-7. PubMed ID: 16505257
[TBL] [Abstract][Full Text] [Related]
16. High INR on warfarin.
Reddy U; Mallepaddi NR; Chevassut TJ
BMJ; 2015 Apr; 350():h1282. PubMed ID: 25858914
[No Abstract] [Full Text] [Related]
17. Evaluation of warfarin management with international normalized ratio self-testing and online remote monitoring and management plus low-dose vitamin k with genomic considerations: a pilot study.
Bussey HI; Bussey M; Bussey-Smith KL; Frei CR
Pharmacotherapy; 2013 Nov; 33(11):1136-46. PubMed ID: 24038412
[TBL] [Abstract][Full Text] [Related]
18. Comparison of oral vs intravenous phytonadione (vitamin K1) in patients with excessive anticoagulation: a prospective randomized controlled study.
Lubetsky A; Yonath H; Olchovsky D; Loebstein R; Halkin H; Ezra D
Arch Intern Med; 2003 Nov; 163(20):2469-73. PubMed ID: 14609783
[TBL] [Abstract][Full Text] [Related]
19. Reversal of coagulopathy using prothrombin complex concentrates is associated with improved outcome compared to fresh frozen plasma in warfarin-associated intracranial hemorrhage.
Frontera JA; Gordon E; Zach V; Jovine M; Uchino K; Hussain MS; Aledort L
Neurocrit Care; 2014 Dec; 21(3):397-406. PubMed ID: 24671832
[TBL] [Abstract][Full Text] [Related]
20. Management of excessive anticoagulant effect due to vitamin K antagonists.
Dentali F; Crowther MA
Hematology Am Soc Hematol Educ Program; 2008; ():266-70. PubMed ID: 19074094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
